Clinical trials
Endocrine Gland Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 12 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Unknown status | 4 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| M.D. Anderson Cancer Center | 3 |
| Catalysis SL | 2 |
| Eli Lilly and Company | 2 |
| KU Leuven | 2 |
| Medical University of Vienna | 2 |
| Sumitomo Pharma America, Inc. | 2 |
| Syndax Pharmaceuticals | 2 |
| University Health Network, Toronto | 2 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine Gland Neoplasms | 49 |
| Neoplasms | 26 |
| Endocrine System Diseases | 19 |
| Digestive System Neoplasms | 14 |
| Neoplasms by Site | 14 |
| Lung Neoplasms | 13 |
| Pancreatic Neoplasms | 13 |
| Breast Neoplasms | 12 |
| Digestive System Diseases | 10 |
| Pancreatic Diseases | 10 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.